The Urban Rainforest
Home The Cities eTrade eTourism Archive About Us Contact Us
No Ads
eTrade Contacts
Major ProductsLocation Of SuppliersExport Markets
Trade FairsForeign Buyers GuideEmbassies
Trade Related Government Regulations & PoliciesCalendar Of EventsGovernment Offices Directory
General Info

eTourism Contacts
MuseumsHotelsResorts
HospitalsCity FestivalsEmergency Numbers
Tourist OperatorsTourist AttractionsSpecial Areas Of Interest
Accredited Travel AgenciesTourism Related Government Regulations & PoliciesUniversities
TransportationGovernment Tourism OfficesGeneral Info

Calendar of Events Contacts
Cultural Calendar

Cultural Calendar Contacts

eTrade Contacts

News: Low-dose aspirin safe for heart protection - 17 Feb 2008
Aspirin is one of the best ways to prevent heart attack and manage heart disease. Newer researches, however, give evidence that low-dose aspirin is safer and better tolerated than higher doses. 

One of these studies showed that taking more than 100 mg of aspirin a day increases the risk of bleeding — from nose bleeds to bleeding in the stomach and the brain.

The study found that serious bleeding occurs in five percent of heart disease patients taking 200 mg or more aspirin daily, but only one percent of heart disease patients taking the lower dose of aspirin experience bleeding. Lower doses such as 30 mg have shown to have excellent tolerability.

Although the study does not address how well different doses of aspirin prevent heart attacks, Dr. Victor Serebruany, a medical researcher at HeartDrug Research in Towson, Maryland, said, “I think it is very probable that low-dose aspirin is as effective as higher doses to prevent second heart attacks.”

Serebruany and his colleagues analyzed data from 31 published studies that included information from 200,000 heart disease patients who were on daily aspirin therapy ranging from 30 mg to 1,300 mg daily.

Commenting on the results of the study, Dr. Robert Bonow of the Northwestern University Feinberg School of Medicine in Chicago, Illinois, said, “I think it’s fairly clear from these data that low-dose aspirin is probably the best choice for prevention — certainly it is the best choice for (preventing first heart attacks).”

Aspirin helps prevent the formation of clots that block blood flow to the heart to prevent heart attacks. It has been used to prevent heart attack in people at high risk of having one and among those who have already suffered from a first heart attack.

Although aspirin has existed for more than a century, it was only in 1998 when the US Food and Drug Administration (FDA) finalized a rule to provide doctors updated information on the use of aspirin for men and women who have had a heart attack or stroke or are at high risk of developing cardiovascular diseases.

Dr. George Sopko, head of the Interventional Cardiology Scientific Research Group at the National Institutes of Health, discussed the benefits of aspirin for the heart.
“Aspirin is a great drug: effective, cheap and relatively safe,” Sopko said. “The drug has been used by just about everybody, so it may not have the appeal of newer drugs, but it can have a huge beneficial impact if used properly. Looking at aspirin’s impact, on heart attack, for example, it may be equal to or better than some drug therapies that cost thousands of dollars.”

According to the US FDA, aspirin is used in the treatment of stroke and transient ischemic attack (mini-stroke).

It is also prescribed to patients with heart attack, had a previous heart attack, have suffered chest pain, and those with complications from heart attack.

It is likewise used to prevent recurrent blockage for those who have had heart bypass surgery or other procedures to clear blocked arteries.

Despite the wonders of aspirin for the heart, not all can have aspirin as their medicine. Dr. Charles Hennekens, chief of preventive medicine at the Brigham and Women’s Hospital in Boston cautioned, “Although aspirin is a familiar and readily available drug, people shouldn’t take it for its cardiovascular benefits without discussing the risks of long-term use with a doctor.”

Aspirin’s most common side effect is stomach bleeding.
An aspirin that causes less stomach bleeding for patients with heart disease is available in the country.
Manufactured by Pascual Laboratories, this heart-shaped tablet has 30 mg aspirin, the lowest dose available in the market today. Patients are advised to consult their doctor for the best medicine for their condition.

Source: PhilStar.com

Posted By: PhilCTTIS Data Center 
 
Date  Title  Action
Article 
10 Oct 2010  BUISNESS DIRECTORY: ORGANIC, HERBAL & NATURAL PRODUCTS  View
05 Oct 2010  BUSINESS DIRECTORY: WEARABLES  View
30 Sep 2010  BUSINESS DIRECTORY: Gifts and Christmas Decors  View
29 Sep 2010  List of State Universities and Colleges in NCR  View
27 Sep 2010  DIRECTORY: Suppliers of IT & IT Enabled Services/Electronics  View
23 Sep 2010  DIRECTORY: Suppliers of Processed Food  View
21 Sep 2010  DIRECTORY: Domestic Suppliers of Accessories (NCR)  View
07 Aug 2010  Brief History of Pasig  View
15 Feb 2008  Important Numbers to Remember  View
15 Nov 2007  Let?s kill poverty  View
01 Oct 2007  Guide to Honeybee Processors  View
Event 
24 Aug 2010  Important Events to Remember  View
13 Jun 2008  CONFERENCE ON BUSINESS DEVELOPMENT FOR UNIVERSITIES JUNE 11-13  View
07 Jun 2008  ASEAN RUBBER CONFERENCE SLATED JUNE 5-7  View
News 
22 Mar 2011  EEI profit soars 17% to P657 M  View
19 Mar 2011  Foreign investors interested in opening 20 gohotels.ph branches  View
03 Dec 2010  ADB to invest in Asia’s water infrastructure  View
13 Oct 2010  NEDA: RP August exports among Southeast Asia’s highest  View
29 Aug 2010  NEDA pushes public-private partnership  View
27 Aug 2010  ADB offers $280-million loan to boost RP's clean air program   View
17 Aug 2010  Jollibee Profit Reaches P1.43 B  View
06 Aug 2010  JG Summit ventures into BPO business  View
02 Aug 2010  San Miguel Pursues Laiban Project  View
13 May 2008  CONFERENCE ON BUSINESS DEVELOPMENT FOR STATE UNIVERSITIES SET IN JUNE  View
08 May 2008  9 scientists, NGO get biotech awards  View
04 May 2008  Online trading spawns new breed of stock investors here  View
27 Apr 2008  SMB prices IPO at P8 per share  View
08 Mar 2008  Novel drug vs hypertension introduced  View
01 Mar 2008  RP firms eye slice of $12-B ME food mart  View
17 Feb 2008  Low-dose aspirin safe for heart protection  View
17 Feb 2008  Estanislao: 65% of PSE-listed co?s now on a par with HK, Thailand  View
17 Feb 2008  Private sector gives P4B for public school projects  View
23 Jan 2008  Suez-Tractebel seeks loans to finance Calaca acquisition  View
12 Jan 2008  ePerformax gets SEC approval for P3.345-B initial public offer  View
18 Nov 2007  SEIPI implements 7 key initiatives to raise electronics exports to $ 45 B  View
01 Nov 2007  Sy sells San Miguel stake  View
28 Oct 2007  Belle Corp posts higher net income of P140M  View
28 Oct 2007  Greenfield Development benefits from boom in business process outsourcing  View
20 Oct 2007  SEC okays PAL Holdings? restructuring  View
20 Oct 2007  Index gains amid solid corporate earnings  View
No Ads
   
Logos and trademarks are the property of their respective owners.
Philippine Cities Trade & Tourism Information Service (c) Copyright 2007, all rights reserved.